Increased thrombin generation in women with recurrent miscarriage

Lancet

Volumn 352, Issue 9122, 1998, Pages 116-

  Vincent, Tonia ^a   Rai, Raj ^a   Regan, Lesley ^a   Cohen, Hannah ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; SPONTANEOUS ABORTION; THROMBOSIS;

EID: 13144254196     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)85022-8     Document Type: Article

References (5)

1. Rushton DI. Placental pathology in spontaneous miscarriage. In: Beard RW, Sharp F, eds. Early pregnancy loss: mechanisms and treatment. London: RCOG, 1988: 149-58.
2. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10: 3301-04.
3. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-16.
4. Gris J, Ripart-Neveu S, Maugard C, et al. Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost 1997; 77: 1096-103.
5. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-57.